LEP and obesity disorder: In vitro evidence has demonstrated that treatment of human umbilical vein endothelial cells with obesity-related levels of leptin (100 ng/mL) greatly increased expression of ET-1 compared to those levels encountered in normal weight humans (~10 ng/mL) [211].